Drawing for NEO-X-PRIME

USPTO serial 79396585

NEO-X-PRIME

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BIBB, SCOTT
Law office
TMEG LAW OFFICE 109

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with NEO-X-PRIME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Antibodies [for scientific and immuno-oncological use]; libraries and collections of antibodies; antibody formats; bispecific antibody formats, therapeutic antibodies; bispecific antibody formats for immuno-oncological applications; bispecific compounds; none of the aforesaid goods being for use in newborn screening and invitro.ACTIVE—
005Antibodies and libraries of antibodies for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for immuno-oncological applications; immuno-oncology preparations for medical and pharmaceutical purposes; antibodies; none of the aforesaid goods being for use in newborn screening and invitro.ACTIVE—
042Bio-technology and scientific research services relating to antibodies, antibody formats, bispecific antibody formats, therapeutic antibodies, and immune-oncology preparations; biochemical research and development in the field of antibodies, protein and enzyme; scientific laboratory services relating to antibodies, protein and enzyme; research, production and development services relating to antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds; research, development and production of immuno-oncology antibody preparations and pharmaceuticals; information, advisory and consultancy services relating to all of the aforesaid services; none of the aforesaid goods being for use in newborn screening and invitro.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2026FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 21, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 21, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 15, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 29, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 29, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 21, 2025MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 21, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 19, 2024RFNTREFUSAL PROCESSED BY IB—
Oct 2, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 2, 2024RFRRREFUSAL PROCESSED BY MPU—
Sep 27, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 26, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 24, 2024DOCKASSIGNED TO EXAMINER—
Jun 1, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 1, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 30, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance